| Dr R Melody Mayordo Reynolds, MD | |
|
1000 Walnut St, Suite 122, Lansdale, PA 19446-1140 | |
| (215) 368-1950 | |
| (215) 368-9923 |
| Full Name | Dr R Melody Mayordo Reynolds |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 1000 Walnut St, Lansdale, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063647899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD449513 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital - Pocono | East stroudsburg, PA | Hospital |
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Care Centers Inc | 5395649347 | 197 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
According to a new survey despite recent improvements in influenza vaccination rates among U.S. health care personnel, their rates for the 2010-2011 flu season still fell short of national health objectives.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
A topical new book about using informatics to reduce healthcare costs edited by Stephan Kudyba, an assistant professor in the NJIT School of Management, will be released early this May. Healthcare Informatics: Improving Efficiency and Productivity addresses the incorporation of information technologies and information management by healthcare providers to increase the efficiencies of their operations to help reduce costs.
› Verified 6 days ago
| Entity Name | Family Care Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669563037 PECOS PAC ID: 5395649347 Enrollment ID: O20031121000497 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
According to a new survey despite recent improvements in influenza vaccination rates among U.S. health care personnel, their rates for the 2010-2011 flu season still fell short of national health objectives.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
A topical new book about using informatics to reduce healthcare costs edited by Stephan Kudyba, an assistant professor in the NJIT School of Management, will be released early this May. Healthcare Informatics: Improving Efficiency and Productivity addresses the incorporation of information technologies and information management by healthcare providers to increase the efficiencies of their operations to help reduce costs.
› Verified 6 days ago
| Entity Name | Fornance Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053363523 PECOS PAC ID: 8527962661 Enrollment ID: O20040216000037 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
According to a new survey despite recent improvements in influenza vaccination rates among U.S. health care personnel, their rates for the 2010-2011 flu season still fell short of national health objectives.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
A topical new book about using informatics to reduce healthcare costs edited by Stephan Kudyba, an assistant professor in the NJIT School of Management, will be released early this May. Healthcare Informatics: Improving Efficiency and Productivity addresses the incorporation of information technologies and information management by healthcare providers to increase the efficiencies of their operations to help reduce costs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr R Melody Mayordo Reynolds, MD 1000 Walnut St, Suite 122, Lansdale, PA 19446-1140 Ph: (215) 368-1950 | Dr R Melody Mayordo Reynolds, MD 1000 Walnut St, Suite 122, Lansdale, PA 19446-1140 Ph: (215) 368-1950 |
News Archive
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
According to a new survey despite recent improvements in influenza vaccination rates among U.S. health care personnel, their rates for the 2010-2011 flu season still fell short of national health objectives.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
A topical new book about using informatics to reduce healthcare costs edited by Stephan Kudyba, an assistant professor in the NJIT School of Management, will be released early this May. Healthcare Informatics: Improving Efficiency and Productivity addresses the incorporation of information technologies and information management by healthcare providers to increase the efficiencies of their operations to help reduce costs.
› Verified 6 days ago
Robert J Filosa, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1000 Walnut Street, Ste 122, Lansdale, PA 19446 Phone: 215-368-1950 Fax: 215-368-9923 | |
Dipti Shah-parikh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Walnut St, Ste 122, Lansdale, PA 19446 Phone: 215-368-1950 Fax: 215-368-9923 | |
Dr. Luis Manuel Espaillat Rijo, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 419 S Broad St Unit 4, Lansdale, PA 19446 Phone: 215-536-3200 Fax: 215-536-3259 | |
Jeanie Lee Yuh, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1000 Walnut St, Suite 122, Lansdale, PA 19446 Phone: 215-481-2606 Fax: 215-368-9923 |